PowderMed
Oxford
About PowderMed
PowderMed developed vaccines for the treatment of chronic infectious diseases and cancer. The company used DNA coated gold particles delivered by a needle-free injection device to stimulate a powerful and specific T cell immune response.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.8M
- Funding stage: M&A
- Last round: Series A (May 2004)
- Website: powdermed.com
- Phone: +441865501500
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/powdermed-278792 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.